SCHULMAN AMY W 4

What Happened

• Amy W. Schulman, a director of Elevance Health, was granted 218 phantom stock units on 2026-02-02 (transaction code A — award/acquisition). The units were reported at an acquisition price of $0.00 (total reported value $0), as these are deferred/phantom units rather than immediate purchases of common stock.

Key Details

• Transaction date: 2026-02-02; Form 4 filed: 2026-02-03 (appears timely).
• Security: 218 phantom stock units; price per unit: $0.00; total reported value: $0.
• Shares owned after transaction: not disclosed in the provided filing details.
• Transaction code: A (grant/award/acquisition).
• Footnotes: F1 — these are phantom stock units under the Board of Directors Compensation Program. F2 — units will be payable in company common stock upon the earlier of (a) five years from the date of the annual meeting immediately before the director’s election date or (b) the date the director leaves the board, unless a later date is elected under the deferred compensation plan.

Context

• Phantom stock units are a form of deferred compensation for directors and are typically settled in company stock at a future date (they are not immediate open-market purchases or sales). Such grants are routine for board compensation and do not by themselves indicate a buy/sell market sentiment.